Cargando…
Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia–reperfusion-induced kidney injury via the JAK/STAT pathway
BACKGROUND: Kidney ischemia–reperfusion injury is a common pathophysiological phenomenon in the clinic. A large number of studies have found that the tyrosine protein kinase/signal transducer and activator of transcription (JAK/STAT) pathway is involved in the development of a variety of kidney dise...
Autores principales: | Zhao, Xiaoying, Zhang, Erfei, Ren, Xiaofen, Bai, Xiaoli, Wang, Dongming, Bai, Ling, Luo, Danlei, Guo, Zheng, Wang, Qiang, Yang, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333427/ https://www.ncbi.nlm.nih.gov/pubmed/32620154 http://dx.doi.org/10.1186/s40659-020-00297-0 |
Ejemplares similares
-
Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion
injury by inhibiting neuroinflammation through the JAK2/STAT3
pathway
por: Liu, Huan, et al.
Publicado: (2022) -
Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway
por: Hu, Guang-qiang, et al.
Publicado: (2017) -
Development
of Edaravone Ionic Liquids and Their Application
for the Treatment of Cerebral Ischemia/Reperfusion Injury
por: Fukuta, Tatsuya, et al.
Publicado: (2023) -
Metabolomic Profiling of Brain Protective Effect of Edaravone on Cerebral Ischemia-Reperfusion Injury in Mice
por: Ma, Hui-fen, et al.
Publicado: (2022) -
Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation
por: Si, Yanna, et al.
Publicado: (2013)